To investigate this finding in a larger number of subjects with a known FLG genotype, we extended our analysis of RAPTOR and filaggrin to a gene expression analysis of nonlesional and nonflexural skin biopsy specimens from 26 patients with AD and 10 nonatopic control subjects of a known FLG genotype, as previously described.21 This evidence concerns the gene FLG and Alzheimer disease.